In July, Pat Morin joined the Ludwig Institute for Cancer Research as deputy scientific director. Pat comes to us from the University of Pennsylvania, where he was executive director for strategic alliances at the Abramson Cancer Center and an adjunct professor at the Perelman School of Medicine. After obtaining his PhD at Boston University in 1995, Pat started his research career as a postdoc studying the Wnt/β-catenin pathway in colorectal cancer in the laboratory led by Bert Vogelstein and Ken Kinzler at what is now the Ludwig Center at Johns Hopkins University. He continued as an adjunct assistant professor at Johns Hopkins and joined the National Institute on Aging of the U.S. National Institutes of Health as a tenure-track investigator studying ovarian cancer, rising to the position of senior investigator at the institute. From 2012 to 2016, he served as the senior director of scientific review and grants administration at the American Association for Cancer Research, where he helped lead the Stand Up to Cancer initiative, before joining the Abramson Cancer Center in 2016. Pat will work with Scientific Director Chi Van Dang and CEO Ed McDermott to direct the Institute’s research activities, select and review scientific staff and help develop and direct strategic initiatives and research collaborations. We extend a warm welcome to Pat on behalf of the larger Ludwig community.
Click here to read a Q&A with Pat Morin.
This article appeared in the September 2022 issue of Ludwig Link. Click here to download a PDF (1 MB).